195 related articles for article (PubMed ID: 31911305)
21. Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin.
Pepe A; Sun L; Zanardi I; Wu X; Ferlini C; Fontana G; Bombardelli E; Ojima I
Bioorg Med Chem Lett; 2009 Jun; 19(12):3300-4. PubMed ID: 19423340
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of de novo cytotoxic alkaloids through mimicking taxoid skeleton.
Geng X; Geney R; Pera P; Bernacki RJ; Ojima I
Bioorg Med Chem Lett; 2004 Jul; 14(13):3491-4. PubMed ID: 15177459
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and structure-activity relationships of nonaromatic taxoids: effects of alkyl and alkenyl ester groups on cytotoxicity.
Ojima I; Kuduk SD; Pera P; Veith JM; Bernacki RJ
J Med Chem; 1997 Jan; 40(3):279-85. PubMed ID: 9022794
[TBL] [Abstract][Full Text] [Related]
24. Overcoming tumor drug resistance with high-affinity taxanes: a SAR study of C2-modified 7-acyl-10-deacetyl cephalomannines.
Yang CG; Barasoain I; Li X; Matesanz R; Liu R; Sharom FJ; Yin DL; Díaz JF; Fang WS
ChemMedChem; 2007 May; 2(5):691-701. PubMed ID: 17385753
[TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships of some taxoids as multidrug resistance modulator.
Hasegawa T; Bai J; Zhang S; Wang J; Matsubara J; Kawakami J; Tomida A; Tsuruo T; Hirose K; Sakai J; Kikuchi M; Abe M; Ando M
Bioorg Med Chem Lett; 2007 Feb; 17(4):1122-6. PubMed ID: 17239597
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological activity of C-7, C-9 and C-10 modified taxane analogues from 1-deoxybaccatin VI.
Xie C; Cui Y; Li L; Zhang M; Liu H; Lin H
Bioorg Med Chem; 2020 Nov; 28(21):115736. PubMed ID: 33065439
[TBL] [Abstract][Full Text] [Related]
28. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
29. Recent progress in the strategic incorporation of fluorine into medicinally active compounds.
Haranahalli K; Honda T; Ojima I
J Fluor Chem; 2019 Jan; 217():29-40. PubMed ID: 31537946
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids.
Sun L; Geng X; Geney R; Li Y; Simmerling C; Li Z; Lauher JW; Xia S; Horwitz SB; Veith JM; Pera P; Bernacki RJ; Ojima I
J Org Chem; 2008 Dec; 73(24):9584-93. PubMed ID: 18975909
[TBL] [Abstract][Full Text] [Related]
31. Biological activity and chemistry of taxoids from the Japanese yew, Taxus cuspidata.
Shigemori H; Kobayashi J
J Nat Prod; 2004 Feb; 67(2):245-56. PubMed ID: 14987066
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Cytotoxicity of 7,9-
Zhao Y; Wang TE; Mills A; Gago F; Fang WS
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181726
[TBL] [Abstract][Full Text] [Related]
33. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and cytotoxicity of 2alpha-amido docetaxel analogues.
Fang WS; Liu Y; Liu HY; Xu SF; Wang L; Fang QC
Bioorg Med Chem Lett; 2002 Jun; 12(11):1543-6. PubMed ID: 12031338
[TBL] [Abstract][Full Text] [Related]
35. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Brooks TA; Minderman H; O'Loughlin KL; Pera P; Ojima I; Baer MR; Bernacki RJ
Mol Cancer Ther; 2003 Nov; 2(11):1195-205. PubMed ID: 14617793
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of novel quinoline-docetaxel analogues.
Chen M; Chen H; Ma J; Liu X; Zhang S
Bioorg Med Chem Lett; 2014 Jul; 24(13):2867-70. PubMed ID: 24835987
[TBL] [Abstract][Full Text] [Related]
37. Isolation, identification, semi-synthesis of aziditaxel derivatives and their biological evaluation.
Zhang SE; Tao JY; Zhao Y; Wang SR; Zhou D; Fang WS
J Asian Nat Prod Res; 2012; 14(5):463-75. PubMed ID: 22530674
[TBL] [Abstract][Full Text] [Related]
38. Medicinal chemistry and chemical biology of new generation taxane antitumor agents.
Ojima I; Geney R; Ungureanu IM; Li D
IUBMB Life; 2002; 53(4-5):269-74. PubMed ID: 12121008
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes.
Galletti E; Magnani M; Renzulli ML; Botta M
ChemMedChem; 2007 Jul; 2(7):920-42. PubMed ID: 17530726
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
